Table 3.

Bivariate analysis of Charlson comorbidities in the study cohort (n = 14,007,813)

Comorbidity	Total cohort (%)	Mortality cohort (%)	p value
Myocardial infarction	2.4	3.8	< 0.001
Congestive heart failure	4.4	4.9	< 0.001
Peripheral vascular disease	0.9	1.3	< 0.001
Cerebrovascular disease	1.7	4.2	< 0.001
Dementia	1.0	1.9	< 0.001
Chronic pulmonary disease	11	1.2	< 0.001
Rheumatic disease	2.0	0.10	< 0.001
Peptic ulcer disease	0.80	0.60	< 0.001
Mild liver disease	0.20	0.90	0.015
Moderate/severe liver disease	0	3.1	< 0.001
Diabetes (no chronic complication)	11	0.50	< 0.001
Diabetes (chronic complication)	0.80	3.4	< 0.001
Hemiplegia or paraplegia	0.30	3.7	< 0.001
Renal failure	0.60	6.3	< 0.001
Any malignancy	0.70	3.5	< 0.001
Leukemia	0.20	2.1	< 0.001
Lymphoma	0.20	0.80	0.94
Metastatic solid tumor	0.40	4.9	< 0.001
AIDS/HIV infection	0.10	0	< 0.001